- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| home:mp:olmesartan [01.16.2012] – paulalbert | home:mp:olmesartan [09.14.2022] (current) – external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== Olmesartan (Benicar) | ====== Olmesartan (Benicar) | ||
| + | < | ||
| Olmesartan medoxomil is often referred by its brand name equivalent, Benicar. Patients on the Marshall Protocol (MP) take 40mg of olmesartan four to six times daily. There is no substitute for olmesartan. | Olmesartan medoxomil is often referred by its brand name equivalent, Benicar. Patients on the Marshall Protocol (MP) take 40mg of olmesartan four to six times daily. There is no substitute for olmesartan. | ||
| Line 83: | Line 83: | ||
| - | {{tag> | + | {{tag>MP olmesartan}} |
| + | < | ||
| ===== Notes and comments ===== | ===== Notes and comments ===== | ||
| Line 107: | Line 108: | ||
| | | ||
| - | Olmecip 40 tablets Ingredients Active Olmesartan Medoxomil INH Inactive Lactose IP (Lactose Monohydrate 200 mesh) Croscarmellose Sodium NF Hydroxy propyl cellulose Klucel LF Microcrystalline cellulose Purified talc Croscarmellose sodium Stearic acid Opadry II 33G28707 white | + | Olmecip 40 tablets Ingredients Active Olmesartan Medoxomil INH Inactive Lactose IP (Lactose Monohydrate 200 mesh) Croscarmellose Sodium NF Hydroxy propyl cellulose Klucel LF Microcrystalline cellulose Purified talc Croscarmellose sodium Stearic acid Opadry II 33G28707 white </ |
home/mp/olmesartan.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.